Logistics giant Matson has delivered a complex set of figures for its most recent quarter. While the company experienced a...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Aldeyra Therapeutics' investigational drug, ADX-2191, marking a...

Medical device innovator AtriCure has delivered a powerful second-quarter performance for 2025, significantly exceeding market expectations. The company not only...

The proposed acquisition of Y-mAbs Therapeutics by SERB Pharmaceuticals has encountered unexpected turbulence, shifting from a seemingly concluded transaction to...

In a notable departure from conventional market practice, real estate investment trust NexPoint Residential has secured a secondary listing. The...

While many consultancies face persistent growth challenges, Bowman Consulting Group stands apart, demonstrating remarkable operational resilience and strategic foresight. The...

The promise of a near 10% dividend yield is a powerful lure for income-focused investors. CTO Realty Growth, a real...

In a digital advertising sector facing significant turbulence, Integral Ad Science Holding LLC has emerged as a notable exception. The...

While much of the market focuses on flashy tech stocks, a key enabler of the artificial intelligence revolution is quietly...

Procter & Gamble's latest quarterly report has presented a complex puzzle for the market. While the consumer goods behemoth posted...